1.Guilleminault, C, Tilkian, A, Dement, WC. The sleep apnea syndromes. Annual Review of Medicine 1976; 27: 465–484.
2.Young, T, et al. The occurrence of sleep-disordered breathing among middle-aged adults. New England Journal of Medicine 1993; 328: 1230–1235.
3.Moyer, CA, et al. Quality of life in obstructive sleep apnea: a systematic review of the literature. Sleep Medicine 2001; 2: 477–491.
4.Punjabi, NM, et al. Sleep-disordered breathing and mortality: a prospective cohort study. PLoS Medicine 2009; 6: e1000132.
5.Punjabi, NM. The epidemiology of adult obstructive sleep apnea. Proceedings of the American Thoracic Society 2008; 5: 136–143.
6.Tufik, S, et al. Obstructive sleep apnea syndrome in the Sao Paulo epidemiologic sleep study. Sleep Medicine 2010; 11: 441–446.
7.Fletcher, EC. Cardiovascular consequences of obstructive sleep apnea: experimental hypoxia and sympathetic activity. Sleep 2000; 23 (Suppl. 4): S127–S131.
8.Wolf, J, Lewicka, J, Narkiewicz, K. Obstructive sleep apnea: an update on mechanisms and cardiovascular consequences. Nutrition, Metabolism, and Cardiovascular Diseases 2007; 17: 233–240.
9.Strohl, KP. Diabetes and sleep apnea. Sleep 1996; 19 (Suppl. 10): S225–S228.
10.Reichmuth, KJ, et al. Association of sleep apnea and type II diabetes: a population-based study. American Journal of Respiratory and Critical Care Medicine 2005; 172: 1590–1595.
11.Smith, R, et al. What are obstructive sleep apnea patients being treated for prior to this diagnosis? Chest 2002; 121: 164–172.
12.van den Akker, M, Buntinx, F, Knottnerus, JA. Comorbidity or multimorbidity what's in a name? A review of literature. European Journal of General Practice [Review] 1999; 2: 65–70.
13.Fortin, M, et al. Prevalence of multimorbidity among adults seen in family practice. Annals of Family Medicine 2005; 3: 223–228.
14.Fortin, M, et al. A systematic review of prevalence studies on multimorbidity: toward a more uniform methodology. Annals of Family Medicine 2012; 10: 142–151.
15.Taylor, AW, et al. Multimorbidity – not just an older person's issue. Results from an Australian biomedical study. BMC Public Health 2010; 10: 718.
16.Salisbury, C, et al. Epidemiology and impact of multimorbidity in primary care: a retrospective cohort study. The British Journal of General Practice 2011; 61: e12–e21.
17.Barnett, K, et al. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet 2012; 380: 37–43.
18.Broemeling, AM, Watson, DE, Prebtani, F. Population patterns of chronic health conditions, co-morbidity and healthcare use in Canada: implications for policy and practice. Healthcare Quarterly (toronto, Ont ) 2008; 11: 70–76.
19.Librero, J, Peiro, S, Ordinana, R. Chronic comorbidity and outcomes of hospital care: length of stay, mortality, and readmission at 30 and 365 days. Journal of Clinical Epidemiology 1999; 52: 171–179.
20.Fortin, M, et al. Psychological distress and multimorbidity in primary care. Annals of Family Medicine 2006; 4: 417–422.
21.Robichaud-Halle, L, Beaudry, M, Fortin, M. Obstructive sleep apnea and multimorbidity. BMC Pulmonary Medicine 2012; 12: 60.
22.Kapur, V, et al. Underdiagnosis of sleep apnea syndrome in U.S. Communities. Sleep & Breathing 2002; 6: 49–54.
23.Young, T, et al. Estimation of the clinically diagnosed proportion of sleep apnea syndrome in middle-aged men and women. Sleep 1997; 20: 705–706.
24.Grant, JF, et al. Cohort profile: the Men androgen inflammation lifestyle environment and stress (MAILES) study. International Journal of Epidemiology 2013; 43: 1040–1053.
25.Berry, RB, et al. Rules for scoring respiratory events in sleep: update of the 2007 AASM manual for the scoring of sleep and associated events. Deliberations of the sleep apnea definitions task force of the American academy of sleep medicine. Journal of Clinical Sleep Medicine 2012; 8: 597–619.
26.Ruehland, WR, et al. The new AASM criteria for scoring hypopneas: impact on the apnea hypopnea index. Sleep 2009; 32: 150–157.
27.Johns, MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991; 14: 540–545.
28.Buysse, DJ, et al. The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Research 1989; 28: 193–213.
29.Chung, F, et al. STOP questionnaire: a tool to screen patients for obstructive sleep apnea. Anesthesiology 2008; 108: 812–821.
30.Grant, JF, et al. Cohort profile: the men androgen inflammation lifestyle environment and stress (MAILES) study. International Journal of Epidemiology 2014; 43: 1040–1053.
31.American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2004; 27 (Suppl. 1): S5–S10.
32.Chittleborough, CR, et al. Health status assessed by the SF-36 along the diabetes continuum in an Australian population. Quality of Life Research 2006; 15: 687–694.
33.AIHW. Australia's health 2010. In: AIHW, editor. Canberra: AIHW; 2010.
34.Radloff, LS, Rae, DS. Susceptibility and precipitating factors in depression: sex differences and similarities. Journal of Abnormal Psychology 1979; 88: 174–181.
35.Lasa, L, et al. The use of the beck depression inventory to screen for depression in the general population: a preliminary analysis. Journal of Affective Disorders 2000; 57(1–3): 261–265.
36.Tucker, G, Adams, R, Wilson, D. New Australian population scoring coefficients for the old version of the SF-36 and SF-12 health status questionnaires. Quality of Life Research 2010; 19: 1069–1076.
37.Ramachandran, SK, Josephs, LA. A meta-analysis of clinical screening tests for obstructive sleep apnea. Anesthesiology 2009; 110: 928–939.
38.Redline, S, et al. Obstructive sleep apnea-hypopnea and incident stroke: the sleep heart health study. American Journal of Respiratory and Critical Care Medicine 2010; 182: 269–277.
39.Lee, CH, et al. Severe obstructive sleep apnea and outcomes following myocardial infarction. Journal of Clinical Sleep Medicine 2011; 7: 616–621.
40.Fortin, M, et al. Multimorbidity and quality of life: a closer look. Health and Quality of Life Outcomes 2007; 5: 52.
41.Finn, L, et al. Sleep-disordered breathing and self-reported general health status in the Wisconsin sleep cohort study. Sleep 1998; 21: 701–706.
42.Siccoli, MM, et al. Effects of continuous positive airway pressure on quality of life in patients with moderate to severe obstructive sleep apnea: data from a randomized controlled trial. Sleep 2008; 31: 1551–1558.
43.Jenkinson, C, et al. Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised prospective parallel trial. Lancet 1999; 353: 2100–2105.
44.Weaver, TE, et al. Continuous positive airway pressure treatment of sleepy patients with milder obstructive sleep apnea: results of the CPAP apnea trial north American program (CATNAP) randomized clinical trial. American Journal of Respiratory and Critical Care Medicine 2012; 186: 677–683.
45.Montserrat, JM, et al. Effectiveness of CPAP treatment in daytime function in sleep apnea syndrome: a randomized controlled study with an optimized placebo. American Journal of Respiratory and Critical Care Medicine 2001; 164: 608–613.
46.Martinez-Garcia, MA, et al. Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension: the HIPARCO randomized clinical trial. JAMA 2013; 310: 2407–2415.
47.Chai-Coetzer, CL, et al. Primary care v. specialist sleep center management of obstructive sleep apnea and daytime sleepiness and quality of life: a randomized trial. JAMA 2013; 309: 997–1004.
48.Chittleborough, CR, et al. Medicare-related service use and costs among people with diagnosed and undiagnosed diabetes and respiratory conditions. Australian Health Review 2009; 33: 107–116.